Effects of Blood Flow Restriction Training on Neuromuscular Function and Performance in Artistic Jump Rope Athletes
Effects of Blood Flow Restriction Training on Upper and Lower Limb Neuromuscular Function, Body Composition, Physiological Responses, and Sport Performance in Artistic Jump Rope Athletes: A Randomized Controlled Trial
The goal of this randomized controlled trial is to investigate whether blood flow restriction training can improve physical function and sports performance in artistic jump rope athletes. The study will include 30 healthy artistic jump rope athletes aged 18 to 25 years. The main questions this study aims to answer are:
- Does blood flow restriction training improve neuromuscular function compared with conventional training?
- Does blood flow restriction training improve muscle strength, power, body composition, physiological responses, and artistic jump rope performance?
Researchers will compare participants receiving blood flow restriction training with participants performing conventional training to determine whether blood flow restriction training provides additional benefits. Participants will complete an 8-week training program and undergo assessments before and after the intervention, including muscle function tests, physical performance tests, body composition measurements, and physiological response evaluations.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Blood flow restriction (BFR) training is an exercise method that uses external pressure to partially restrict blood flow during exercise. This method may allow individuals to achieve improvements in muscle function and physical performance while using lower exercise loads. However, the effects of BFR training in artistic jump rope athletes are not fully understood.
The purpose of this study is to examine the effects of an 8-week blood flow restriction training program on neuromuscular function, body composition, physiological responses, and sport-specific performance in artistic jump rope athletes.
Approximately 30 healthy artistic jump rope athletes aged 18 to 25 years will participate in this study. Participants will be randomly assigned to either a blood flow restriction training group or a conventional training group. Both groups will continue their regular artistic jump rope training during the intervention period. The blood flow restriction training group will complete selected training sessions with individualized blood flow restriction pressure.
Before and after the 8-week intervention, researchers will assess changes in neuromuscular function, upper and lower limb muscle strength, explosive power, jump rope-specific performance, body composition, heart rate responses, and blood lactate responses.
This study may provide information about whether blood flow restriction training can be used as an effective training strategy to improve physical function and performance characteristics in artistic jump rope athletes.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Shijun Jin, student
- Número de telefone: 86+15670976576
- E-mail: 15670976576@163.com
Estude backup de contato
- Nome: Liubin Fu, Student
- Número de telefone: 86+15329763941
- E-mail: 1076102965@qq.cn
Locais de estudo
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200000
- Shanghai University of Sport, School of Physical EducationKun
-
Contato:
- Kun Zhu, Professor
- Número de telefone: 86+13938431772
- E-mail: zhukun@sus.edu.cn
-
Contato:
- Shijun Jin, Student
- Número de telefone: 86+15670976576
- E-mail: applecatt2002@gmail.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- Adults aged 18 to 25 years.
- Current artistic jump rope athletes with at least 2 years of regular artistic jump rope training experience.
- Participants who are able to perform artistic jump rope skills and complete all study-related assessments and training procedures.
- Participants who are physically healthy and have no medical conditions that may interfere with exercise testing or blood flow restriction training.
- Participants who have no acute or chronic musculoskeletal injuries affecting the upper limbs, lower limbs, or trunk.
- Participants who voluntarily agree to participate and provide written informed consent before enrollment.
Exclusion Criteria:
- Participants younger than 18 years or older than 25 years.
- Presence of cardiovascular disease, peripheral vascular disease, respiratory disease, neurological disease, metabolic disease, coagulation disorders, history of thrombosis, severe varicose veins, severe hypertension, or other conditions that may affect exercise safety.
- Presence of acute or chronic musculoskeletal injuries, including injuries involving muscles, joints, ligaments, tendons, or bones, that prevent safe completion of study procedures.
- Significant pain, severe fatigue, insufficient recovery, poor sleep condition, or other health conditions that may affect exercise performance or participant safety.
- Use of medications, nutritional supplements, or sports supplements within the previous week that may influence cardiovascular function, muscle metabolism, blood lactate response, heart rate variability, neuromuscular activation, fatigue response, or exercise performance.
- Skin damage, infection, dermatological disorders, severe allergy history, or other conditions affecting blood flow restriction cuff application or surface electromyography electrode placement.
- Inability to understand the study procedures or inability to complete required assessments, including physical performance tests, blood flow restriction training, or blood lactate testing.
- Refusal to participate in blood flow restriction training or withdrawal of informed consent during the study.
Exclusion Criteria:
1. Age younger than 18 years or older than 25 years. 2. Presence of cardiovascular disease, peripheral vascular disease, respiratory disease, neurological disease, metabolic disease, coagulation abnormalities, history of thrombosis, severe varicose veins, severe hypertension, or other conditions that may affect exercise testing or blood flow restriction training safety.
3. Current acute or chronic injuries involving muscles, joints, ligaments, tendons, or bones that prevent safe completion of study procedures.
4. Severe fatigue, poor recovery status, significant pain, insufficient sleep, or other conditions that may influence exercise performance or participant safety.
5. Use of medications, nutritional supplements, or sports supplements that may affect cardiovascular function, muscle metabolism, blood lactate response, heart rate variability, neuromuscular activation, fatigue response, or exercise performance within the previous week.
6. Skin damage, infection, dermatological disorders, severe allergy history, or other conditions affecting blood flow restriction cuff application or surface electromyography electrode placement.
7. Inability or unwillingness to complete study assessments, blood flow restriction training, blood lactate testing, or other required procedures.
8. Withdrawal of consent or inability to comply with the study protocol during the intervention period.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Outro
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Blood Flow Restriction Training Group
|
An 8-week blood flow restriction training program combined with regular artistic jump rope training.
External pressure will be applied using a blood flow restriction device during selected training sessions.
|
|
Comparador Ativo: Conventional Training Group
|
An 8-week conventional artistic jump rope training program without blood flow restriction.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Neuromuscular Function Assessed by Surface Electromyography and Maximal Voluntary Contraction
Prazo: Baseline and after 8 weeks of intervention
|
Neuromuscular function will be assessed using surface electromyography (sEMG) and maximal voluntary contraction (MVC) testing.
Outcome measures include muscle activation amplitude, root mean square (RMS, μV), integrated electromyography (iEMG, μV·s), mean power frequency (MPF, Hz), and maximal voluntary contraction force (N).
|
Baseline and after 8 weeks of intervention
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Change in Upper Limb Muscle Strength Assessed by Hand Grip Strength Test
Prazo: Baseline and after 8 weeks of intervention
|
Upper limb muscle strength will be assessed using grip strength testing.
The outcome measure is maximal voluntary grip force (kg) measured during maximal effort contraction.
|
Baseline and after 8 weeks of intervention
|
|
Change in One-Repetition Maximum Strength
Prazo: Baseline and after 8 weeks of intervention
|
Maximal muscle strength will be assessed using one-repetition maximum (1RM) testing.
The outcome measure is the maximal load successfully completed during the strength test (kg).
|
Baseline and after 8 weeks of intervention
|
|
Change in Lower Limb Explosive Power Assessed by Three-Dimensional Force Platform
Prazo: Baseline and after 8 weeks of intervention
|
Lower limb explosive power and jump performance will be assessed using a three-dimensional force platform during jump testing.
Outcome measures include jump height (cm), peak ground reaction force (N), peak power output (W), and rate of force development (N/s).
|
Baseline and after 8 weeks of intervention
|
|
Change in Upper Limb Anaerobic Power During Wingate Test
Prazo: Baseline and after 8 weeks of intervention
|
Upper limb anaerobic power will be assessed using a 30-second upper limb Wingate test performed on an arm crank ergometer.
Outcome measures include peak power output (W), mean power output (W), relative peak power output (W/kg), total work (J), and fatigue index (%).
|
Baseline and after 8 weeks of intervention
|
|
Change in Lower Limb Anaerobic Power During Wingate Test
Prazo: Baseline and after 8 weeks of intervention
|
Lower limb anaerobic power will be assessed using Wingate cycling tests.
Outcome measures include peak power output (W), mean power output (W), relative peak power output (W/kg), total work (J), and fatigue index (%).
A 6-second Wingate test will assess explosive power, and a 30-second Wingate test will assess anaerobic capacity and fatigue-related performance.
|
Baseline and after 8 weeks of intervention
|
|
Change in Body Composition Assessed by Dual-Energy X-ray Absorptiometry
Prazo: Baseline and after 8 weeks of intervention
|
Body composition will be assessed using dual-energy X-ray absorptiometry (DXA).
Outcome measures include body mass (kg), body fat percentage (%), fat mass (kg), lean body mass (kg), and bone mineral content (kg).
|
Baseline and after 8 weeks of intervention
|
|
Change in Physiological Responses During Exercise
Prazo: Baseline and 8 weeks after intervention
|
Physiological responses will be assessed using heart rate monitoring and blood lactate testing.
Outcome measures include resting heart rate (beats/min), peak heart rate (beats/min), heart rate recovery (beats/min), and blood lactate concentration (mmol/L).
|
Baseline and 8 weeks after intervention
|
|
Change in Dynamic Balance Performance
Prazo: Baseline and 8 weeks after intervention
|
Dynamic balance performance will be assessed using the Y Balance Test.
Outcome measures include anterior reach distance (cm), posteromedial reach distance (cm), posterolateral reach distance (cm), and composite reach score (%).
|
Baseline and 8 weeks after intervention
|
|
Change in Short-Duration Rope Turning Performance
Prazo: Baseline and after 8 weeks of intervention
|
Short-duration rope turning performance will be assessed using a 10-second maximal rope turning test.
Outcome measures include total repetitions completed within 10 seconds and average movement frequency (repetitions/s).
|
Baseline and after 8 weeks of intervention
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: kun Zhu, Professor, Shanghai University of Sport
- Diretor de estudo: Jing Wang, Student, Shanghai University of Sport
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 102772026RT119
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .